US Hospitals Rush to Deploy Branded AI Chatbots as Patients Turn to LLMs for Health Advice

American patients are increasingly bypassing traditional channels, turning directly to large language models like ChatGPT for preliminary health advice. In response, major US health systems are rapidly developing and deploying their own branded AI chatbots. This strategic pivot aims to capture this growing user behavior and funnel it back into their own networks, but it immediately collides with the deep-seated complexities and documented underperformance of the nation's healthcare infrastructure.

Hospital executives publicly frame these AI tools as a matter of patient convenience and digital equity—a way to meet people 'where they are.' A core argument is that these institution-controlled bots will provide a safer, more reliable alternative to the unvetted commercial AI models the public is already using. Allon Bloch, CEO of clinical AI company K Health, encapsulates the industry sentiment, stating, 'We are at an inflection point in healthcare. Demand is accelerating, and patients are already using AI to navigate their lives.'

The trend, however, raises immediate and serious questions. Integrating AI chatbots into patient care pathways introduces new risks around accuracy, liability, and data privacy within a system already strained by access and quality issues. The move signals a reactive, competitive scramble by hospitals to control the narrative and the patient entry point, potentially prioritizing institutional steering over resolving the fundamental challenges that drive patients to seek answers from AI in the first place.